vs
CORCEPT THERAPEUTICS INC（CORT）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
CORCEPT THERAPEUTICS INC的季度营收约是Rocket Lab Corp的1.1倍（$202.1M vs $179.7M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs -29.5%，领先41.5%），Rocket Lab Corp同比增速更快（35.7% vs 11.1%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 17.3%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
CORT vs RKLB — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $179.7M |
| 净利润 | $24.3M | $-52.9M |
| 毛利率 | 98.7% | 38.0% |
| 营业利润率 | 2.2% | -28.4% |
| 净利率 | 12.0% | -29.5% |
| 营收同比 | 11.1% | 35.7% |
| 净利润同比 | -21.0% | -1.1% |
| 每股收益（稀释后） | $0.20 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $202.1M | $179.7M | ||
| Q3 25 | $207.6M | $155.1M | ||
| Q2 25 | $194.4M | $144.5M | ||
| Q1 25 | $157.2M | $122.6M | ||
| Q4 24 | $181.9M | $132.4M | ||
| Q3 24 | $182.5M | $104.8M | ||
| Q2 24 | $163.8M | $106.3M | ||
| Q1 24 | $146.8M | $92.8M |
| Q4 25 | $24.3M | $-52.9M | ||
| Q3 25 | $19.7M | $-18.3M | ||
| Q2 25 | $35.1M | $-66.4M | ||
| Q1 25 | $20.5M | $-60.6M | ||
| Q4 24 | $30.7M | $-52.3M | ||
| Q3 24 | $47.2M | $-51.9M | ||
| Q2 24 | $35.5M | $-41.6M | ||
| Q1 24 | $27.8M | $-44.3M |
| Q4 25 | 98.7% | 38.0% | ||
| Q3 25 | 97.8% | 37.0% | ||
| Q2 25 | 98.2% | 32.1% | ||
| Q1 25 | 98.5% | 28.8% | ||
| Q4 24 | 98.4% | 27.8% | ||
| Q3 24 | 98.4% | 26.7% | ||
| Q2 24 | 98.5% | 25.6% | ||
| Q1 24 | 98.3% | 26.1% |
| Q4 25 | 2.2% | -28.4% | ||
| Q3 25 | 4.9% | -38.0% | ||
| Q2 25 | 13.7% | -41.3% | ||
| Q1 25 | 2.2% | -48.3% | ||
| Q4 24 | 13.9% | -38.9% | ||
| Q3 24 | 25.5% | -49.5% | ||
| Q2 24 | 21.7% | -40.7% | ||
| Q1 24 | 20.1% | -46.4% |
| Q4 25 | 12.0% | -29.5% | ||
| Q3 25 | 9.5% | -11.8% | ||
| Q2 25 | 18.1% | -46.0% | ||
| Q1 25 | 13.1% | -49.5% | ||
| Q4 24 | 16.9% | -39.5% | ||
| Q3 24 | 25.9% | -49.6% | ||
| Q2 24 | 21.7% | -39.2% | ||
| Q1 24 | 18.9% | -47.7% |
| Q4 25 | $0.20 | $-0.09 | ||
| Q3 25 | $0.16 | $-0.03 | ||
| Q2 25 | $0.29 | $-0.13 | ||
| Q1 25 | $0.17 | $-0.12 | ||
| Q4 24 | $0.25 | $-0.11 | ||
| Q3 24 | $0.41 | $-0.10 | ||
| Q2 24 | $0.32 | $-0.08 | ||
| Q1 24 | $0.25 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $647.8M | $1.7B |
| 总资产 | $836.7M | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
| Q4 25 | $372.2M | $1.0B | ||
| Q3 25 | $421.7M | $976.7M | ||
| Q2 25 | $342.2M | $688.1M | ||
| Q1 25 | $322.8M | $428.4M | ||
| Q4 24 | $383.3M | $419.0M | ||
| Q3 24 | $380.3M | $442.4M | ||
| Q2 24 | $473.2M | $496.8M | ||
| Q1 24 | $410.8M | $492.5M |
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
| Q4 25 | $647.8M | $1.7B | ||
| Q3 25 | $631.9M | $1.3B | ||
| Q2 25 | $635.8M | $688.5M | ||
| Q1 25 | $683.3M | $431.3M | ||
| Q4 24 | $679.6M | $382.5M | ||
| Q3 24 | $638.8M | $419.8M | ||
| Q2 24 | $596.2M | $455.2M | ||
| Q1 24 | $547.9M | $478.9M |
| Q4 25 | $836.7M | $2.3B | ||
| Q3 25 | $823.6M | $2.2B | ||
| Q2 25 | $801.7M | $1.6B | ||
| Q1 25 | $846.5M | $1.3B | ||
| Q4 24 | $840.6M | $1.2B | ||
| Q3 24 | $784.3M | $1.2B | ||
| Q2 24 | $714.6M | $1.2B | ||
| Q1 24 | $655.9M | $1.2B |
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $-114.2M |
| 自由现金流率自由现金流/营收 | 19.0% | -63.6% |
| 资本支出强度资本支出/营收 | 0.0% | 27.6% |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
| Q4 25 | $38.4M | $-64.5M | ||
| Q3 25 | $54.5M | $-23.5M | ||
| Q2 25 | $43.9M | $-23.2M | ||
| Q1 25 | $5.1M | $-54.2M | ||
| Q4 24 | $59.3M | $-2.4M | ||
| Q3 24 | $73.8M | $-30.9M | ||
| Q2 24 | $41.2M | $-13.0M | ||
| Q1 24 | $23.8M | $-2.6M |
| Q4 25 | $38.4M | $-114.2M | ||
| Q3 25 | — | $-69.4M | ||
| Q2 25 | $43.9M | $-55.3M | ||
| Q1 25 | $5.0M | $-82.9M | ||
| Q4 24 | $59.2M | $-23.9M | ||
| Q3 24 | $72.2M | $-41.9M | ||
| Q2 24 | $40.8M | $-28.3M | ||
| Q1 24 | — | $-21.8M |
| Q4 25 | 19.0% | -63.6% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | 22.6% | -38.3% | ||
| Q1 25 | 3.2% | -67.6% | ||
| Q4 24 | 32.5% | -18.1% | ||
| Q3 24 | 39.5% | -40.0% | ||
| Q2 24 | 24.9% | -26.7% | ||
| Q1 24 | — | -23.5% |
| Q4 25 | 0.0% | 27.6% | ||
| Q3 25 | 0.0% | 29.6% | ||
| Q2 25 | 0.0% | 22.2% | ||
| Q1 25 | 0.1% | 23.4% | ||
| Q4 24 | 0.1% | 16.3% | ||
| Q3 24 | 0.9% | 10.5% | ||
| Q2 24 | 0.3% | 14.4% | ||
| Q1 24 | 0.0% | 20.7% |
| Q4 25 | 1.58× | — | ||
| Q3 25 | 2.77× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
